Respiratory syncytial virus (RSV) caused significant hospitalizations and severe outcomes in adults, especially those aged 75 ...

Part 3 of this series for Global Biosimilars Week, penned by Dracey Poore, director of biosimilars at Cardinal Health, ...

For a fifth time this year, the FDA has scolded a pharma company for misleading marketing, this time over a Merz ...

The new rules instruct drugmakers to use simple, consumer-friendly language when describing their drugs, without medical ...

Clinical development and trial testing of vesleteplirsen (SRP-5051) for Duchenne muscular dystrophy (DMD) was stopped, with ...

Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...

The day after the election, some celebrated Trump's win and RFK Jr.'s potential role as a public health decision-maker. Why?

The FDA designated 166 products under its breakthrough devices program in its most recent financial year, reversing the ...

A disturbance swirling in the Caribbean Sea developed into Tropical Depression Nineteen early Thursday morning. Forecasters ...

Organon is a strong investment opportunity with a high yield, diversified portfolio, steady performance, and transformative ...

Facing with a dialogue with RFK Jr., a top FDA official mounts a public defense of vaccines — and pleads for open minds.

SiPhox Health, with MIT roots, is developing a home blood testing device using a silicon photonic chip, yet to be FDA ...